UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 145

Sortiert nach

Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial

Journal of the American College of Cardiology, 2017-03, Vol.69 (11), p.1372-1382

2017

Link zum Volltext

Verfügbarkeit prüfen

Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease

Journal of the American College of Cardiology, 2017-03, Vol.69 (11), p.1363-1371

2017

Link zum Volltext

Verfügbarkeit prüfen

Non-Vitamin K Antagonist Oral Anticoagulants for Cardioversion in Atrial Fibrillation: An Updated Meta-analysis

The American journal of medicine, 2017-04, Vol.130 (4), p.457-461

2017

Link zum Volltext

Verfügbarkeit prüfen

The new oral anticoagulants in atrial fibrillation: Once daily or twice daily?

Vascular pharmacology, 2013-09, Vol.59 (3), p.53-62

2013

Link zum Volltext

Verfügbarkeit prüfen

Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials

The American journal of medicine, 2015-09, Vol.128 (9), p.1007-1014.e2

2015

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Physical Activity and Inactivity on Cardiovascular Risk across Women's Lifespan: An Updated Review

Journal of clinical medicine, 2023-06, Vol.12 (13), p.4347

2023

Link zum Volltext

Verfügbarkeit prüfen

Direct oral anticoagulants in patients with bioprosthetic heart valves

Internal and emergency medicine, 2023-08, Vol.18 (5), p.1269-1272

Renda, Giulia

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19

Journal of thrombosis and thrombolysis, 2021-10, Vol.52 (3), p.782-790

2021

Link zum Volltext

Verfügbarkeit prüfen

Awake Blood Pressure Variability, Inflammatory Markers and Target Organ Damage in Newly Diagnosed Hypertension

Hypertension research, 2008-12, Vol.31 (12), p.2137-2146

2008

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of non‐resistant and resistant masked uncontrolled hypertension detected by ambulatory blood pressure monitoring

The journal of clinical hypertension (Greenwich, Conn.), 2022-05, Vol.24 (5), p.591-597

2022

Link zum Volltext

Verfügbarkeit prüfen

Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis

International journal of molecular sciences, 2021-03, Vol.22 (6), p.3049

2021

Link zum Volltext

Verfügbarkeit prüfen

Updated antithrombotic strategies to reduce the burden of cardiovascular recurrences in patients with chronic coronary syndrome

Biomedicine & pharmacotherapy, 2021-08, Vol.140, p.111783-111783, Article 111783

2021

Link zum Volltext

Verfügbarkeit prüfen

Ex Vivo Antiplatelet Effects of Oral Anticoagulants

Journal of cardiovascular development and disease, 2024-04, Vol.11 (4), p.111

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical use of aspirin in ischemic heart disease: past, present and future

Current pharmaceutical design, 2012, Vol.18 (33), p.5215

2012

Link zum Volltext

Verfügbarkeit prüfen

Revisiting Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Current Practice and Novel Perspectives

Journal of clinical medicine, 2023-09, Vol.12 (17), p.5710

2023

Link zum Volltext

Verfügbarkeit prüfen

Sex Differences in Heart Failure: What Do We Know?

Journal of cardiovascular development and disease, 2023-06, Vol.10 (7), p.277

2023

Link zum Volltext

Verfügbarkeit prüfen

Ambulatory blood pressure and risk of new‐onset atrial fibrillation in treated hypertensive patients

The journal of clinical hypertension (Greenwich, Conn.), 2021-01, Vol.23 (1), p.147-152

2021

Link zum Volltext

Verfügbarkeit prüfen

Non-Vitamin K Oral Anticoagulants (NOAC) Versus Vitamin K Antagonists (VKA) for Atrial Fibrillation with Elective or Urgent Percutaneous Coronary Intervention: A Meta-Analysis with a Particular Focus on Combination Type

Journal of clinical medicine, 2020-04, Vol.9 (4), p.1120

2020

Link zum Volltext

Verfügbarkeit prüfen

A real-world multicenter study on left atrial appendage occlusion: The Italian multi-device experience

International journal of cardiology. Heart & vasculature, 2024-04, Vol.51, p.101391-101391, Article 101391

2024

Link zum Volltext

Verfügbarkeit prüfen

Predictors of Mortality and Cardiovascular Outcome at 6 Months after Hospitalization for COVID-19

Journal of clinical medicine, 2022-01, Vol.11 (3), p.729

2022

Link zum Volltext

Verfügbarkeit prüfen

Predictive Value of Left Atrial and Ventricular Strain for the Detection of Atrial Fibrillation in Patients With Cryptogenic Stroke

Frontiers in cardiovascular medicine, 2022-04, Vol.9, p.869076-869076

2022

Link zum Volltext

Verfügbarkeit prüfen

Role of CES1 and ABCB1 Genetic Polymorphisms on Functional Response to Dabigatran in Patients with Atrial Fibrillation

Journal of clinical medicine, 2024-04, Vol.13 (9), p.2545

2024

Link zum Volltext

Verfügbarkeit prüfen

Mortality Prediction of the CHA2DS2-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial Fibrillation

Journal of clinical medicine, 2020-12, Vol.9 (12), p.3987

2020

Link zum Volltext

Verfügbarkeit prüfen

Case Report: Mitral Valve Involvement and First-Degree Atrial-Ventricular Block in Two Patients With Multisystem Inflammatory Syndrome in Children

Frontiers in pediatrics, 2021-08, Vol.9

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation

The American journal of medicine, 2016-10, Vol.129 (10), p.1117-1123.e2

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 145

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(135)
Mit Volltextzugriff
(124)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(108)
Life Sciences & Biomedicine
(104)
Humans
(78)
Cardiovascular System & Cardiology
(57)
Cardiac & Cardiovascular Systems
(47)
Female
(40)
Male
(37)
Atrial Fibrillation
(36)
Risk Factors
(31)
Aged
(29)
Anticoagulants
(25)
Middle Aged
(25)
Atrial Fibrillation - Complications
(23)
Cardiac Arrhythmia
(21)
Clinical Medicine
(21)
General & Internal Medicine
(21)
Medicine, General & Internal
(21)
Stroke
(21)
Treatment Outcome
(19)
Mortality
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial

Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease

Non-Vitamin K Antagonist Oral Anticoagulants for Cardioversion in Atrial Fibrillation: An Updated Meta-analysis

The new oral anticoagulants in atrial fibrillation: Once daily or twice daily?

Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials

The Impact of Physical Activity and Inactivity on Cardiovascular Risk across Women's Lifespan: An Updated Review

Direct oral anticoagulants in patients with bioprosthetic heart valves

Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19

Awake Blood Pressure Variability, Inflammatory Markers and Target Organ Damage in Newly Diagnosed Hypertension

Prognostic value of non‐resistant and resistant masked uncontrolled hypertension detected by ambulatory blood pressure monitoring

Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis

Updated antithrombotic strategies to reduce the burden of cardiovascular recurrences in patients with chronic coronary syndrome

Ex Vivo Antiplatelet Effects of Oral Anticoagulants

Clinical use of aspirin in ischemic heart disease: past, present and future

Revisiting Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Current Practice and Novel Perspectives

Sex Differences in Heart Failure: What Do We Know?

Ambulatory blood pressure and risk of new‐onset atrial fibrillation in treated hypertensive patients

Non-Vitamin K Oral Anticoagulants (NOAC) Versus Vitamin K Antagonists (VKA) for Atrial Fibrillation with Elective or Urgent Percutaneous Coronary Intervention: A Meta-Analysis with a Particular Focus on Combination Type

A real-world multicenter study on left atrial appendage occlusion: The Italian multi-device experience

Predictors of Mortality and Cardiovascular Outcome at 6 Months after Hospitalization for COVID-19

Predictive Value of Left Atrial and Ventricular Strain for the Detection of Atrial Fibrillation in Patients With Cryptogenic Stroke

Role of CES1 and ABCB1 Genetic Polymorphisms on Functional Response to Dabigatran in Patients with Atrial Fibrillation

Mortality Prediction of the CHA2DS2-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial Fibrillation

Case Report: Mitral Valve Involvement and First-Degree Atrial-Ventricular Block in Two Patients With Multisystem Inflammatory Syndrome in Children

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation

Suchergebnisse filtern